(Q37661050)

21 August 2017

1 reference

title

Is there a role for erythropoietin in cardiovascular disease? (English)

1 reference

Christodoulos I. Stefanadis

21 August 2017

cardiovascular disease

1 reference

1 reference

series ordinal

5

object named as

Christodoulos Stefanadis

1 reference

21 August 2017

3

Dimitris Tousoulis

1 reference

PubMed ID

20028188

21 August 2017

Alexandros Briasoulis

series ordinal

2

object named as

Alexandros Briasoulis

1 reference

21 August 2017

1

Georgia Vogiatzi

1 reference

21 August 2017

Nikolaos Papageorgiou

series ordinal

4

1 reference

PubMed ID

20028188

21 August 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Expert Opinion on Biological Therapy

21 August 2017

1 reference

21 August 2017

10

1 reference

21 August 2017

2

1 reference

21 August 2017

251-264

1 reference

Myocardial reperfusion injury.

21 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin receptor mRNA expression in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin and erythropoietin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Cytokine and cytokine receptor pleiotropy and redundancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Overview: erythropoiesis, anemia, and the impact of erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin-mediated tissue protection: reducing collateral damage from the primary injury response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Emerging biological roles for erythropoietin in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

The pleiotropic effects of erythropoietin in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

New avenues of exploration for erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin involves the phosphatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafficking to preserve endothelial cell integrity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Molecular basis of cardioprotection by erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin in the brain: can the promise to protect be fulfilled?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin is a novel vascular protectant through activation of Akt1 and mitochondrial modulation of cysteine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, and 8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Role of heme oxygenase-1 in the cardioprotective effects of erythropoietin during myocardial ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin protects the heart from ventricular arrhythmia during ischemia and reperfusion via neuronal nitric-oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

"Sly as a FOXO": new paths with Forkhead signaling in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin stimulates vasculogenesis in neonatal rat mesenteric microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Protective effects of erythropoietin in cardiac ischemia: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

A novel protective effect of erythropoietin in the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Cardioprotection by recombinant human erythropoietin following acute experimental myocardial infarction: dose response and therapeutic window

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin regulates endothelial progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin and VEGF exhibit equal angiogenic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Derivatives of erythropoietin that are tissue protective but not erythropoietic

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

High serum erythropoietin level is associated with smaller infarct size in patients with acute myocardial infarction who undergo successful primary percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Effect of EPO administration on myocardial infarct size in patients with non-STE acute coronary syndromes; results from a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol-3 kinase and ERK1/2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Effect of 1-week treatment with erythropoietin on the vascular endothelial function in anaesthetized rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Effects of recombinant human erythropoietin on antiplatelet action of aspirin and clopidogrel in healthy subjects: results of a double-blind, placebo-controlled randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Etiology of anemia in patients with advanced heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Clinical trials update from the European Society of Cardiology Heart Failure meeting and the American College of Cardiology: darbepoetin alfa study, ECHOS, and ASCOT-BPLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Erythropoietin treatment in patients with chronic heart failure: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Normalization of hemoglobin level in patients with chronic kidney disease and anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Structural design and molecular evolution of a cytokine receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712590903547819

10.1517/14712590903547819

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

20028188